Volume 16, Issue 1 , Pages 29-34, January 2007
Recombinant factor VIIa in massive postpartum haemorrhage
Summary
Massive postpartum haemorrhage is a major cause of maternal and fetal morbidity and mortality. Management mainstays include transfusion therapy, uterotonic agents and surgery. The “off label” use of recombinant activated factor VII appears to have an evolving role in the management of massive postpartum haemorrhage refractory to conventional treatments. The current literature is reviewed.
Keywords: Postpartum haemorrhage, Factor VIIa, Anaesthesia, Obstetrics
To access this article, please choose from the options below
PII: S0959-289X(06)00159-2
doi:10.1016/j.ijoa.2006.09.001
© 2006 Elsevier Ltd. All rights reserved.
Volume 16, Issue 1 , Pages 29-34, January 2007
